RXRX · Biotech
AI-driven drug discovery platform combining machine learning with biology automation.
Price
…$5.95
+1.80% today
AI Opportunity Score
60 / 100
Estimate, not a recommendation.
Risk for beginners
Higher
Industry
Biotech
Emerging growth theme
Price trend · Recursion Pharmaceuticals
Educational only · Past performance does not guarantee future results.
AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.
Why it may still be early
AI-driven drug R&D is early innings industry-wide.
How the industry may expand
Pharma R&D spend over $250B per year.
Compared to larger competitors
Differentiated platform play vs traditional biotech.
Mixed exit signals
No urgent signals either way — a calm moment to reflect on your goals.
High-volatility phase
Worth monitoringWhy: Volatility for Recursion Pharmaceuticals is elevated (80/100), so swings in either direction may be larger than usual.
What changed: Daily price ranges have widened.
When investors sometimes consider selling
Rebound potential analysis
Possible rebound factors — these are estimates, not guarantees.
Temporary volatility
Volatile periods can see quick reversals in either direction. Reactions tend to fade faster than fundamentals shift.
Rebound timing and magnitude are uncertain. Markets can stay weak longer than expected.
Estimate possible outcomes across different time horizons. AI-generated estimates only — actual market performance may vary significantly.
Investment amount
$500
After 6 mo
Conservative
$403.11
Expected
$591.61
Bullish
$866.03
After 1 yr
Conservative
$325.00
Expected
$700.00
Bullish
$1500.00
After 3 yr
Conservative
$137.31
Expected
$1372.00
Bullish
$13500.00
After 5 yr
Conservative
$58.01
Expected
$2689.12
Bullish
$121500.00
AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.
About this AI estimate
Availability across popular investing platforms. Always confirm fees and limits in the app you choose.
Robinhood
Fidelity Investments
Fractional shares from $1
Charles Schwab
Stock Slices from $5
Webull
Educational availability info — not a recommendation of any broker.
Legal disclaimer